MiniMax, a Chinese AI startup, has unveiled its new M2.5 language model, promising high-end artificial intelligence at a fraction of the cost of competitors like Claude Opus. The model, released in two variants, is open-source under a modified MIT License, requiring commercial users to prominently display "MiniMax M2.5" on their user interface, according to VentureBeat.
The release of M2.5 has sent shockwaves through the AI industry due to its affordability. MiniMax is offering the model through its API and those of its partners at a significantly lower price point. This could potentially disrupt the market, making powerful AI more accessible.
In other news, American speedskater Jordan Stolz secured his second gold medal at the Milan Cortina Olympics, winning the men's 500-meter race on Saturday, according to NPR News. Stolz, who had previously won the 1,000-meter race, is now two for two in his bid for four gold medals, joining Eric Heiden as the only skaters to win both the 500 and 1,000 meters.
Meanwhile, in the realm of health, a new drug is showing promise in treating preeclampsia, a dangerous complication of pregnancy. Abigail Hendricks, who benefited from a new drug trial, shared her experience with NPR, stating, "For me, a baby is a blessing." Hendricks, who was pregnant with her fifth child, faced health risks due to preeclampsia.
In related developments, a research team from the Institute of Solid State Physics, Hefei Institutes of Physical Science, Chinese Academy of Sciences, in collaboration with Wenzhou University, developed gradient cathodes to boost the stability of Li-rich batteries, according to Phys.org.
Also, Jim O'Neill, the US deputy health secretary, discussed his plans to increase human healthspan through longevity-focused research supported by ARPA-H in an exclusive interview with MIT Technology Review. O'Neill oversees a department with a budget of over a trillion dollars and signed the decision memorandum on the US's new vaccine schedule.
Discussion
AI Experts & Community
Be the first to comment